Nov. 28, 2006— The Meharry/Vanderbilt-Ingram Cancer Partnership has been awarded $14 million by the National Cancer Institute for research that seeks to reduce cancer mortality among African Americans and other minorities.
Vanderbilt-Ingram Cancer Center, AstraZeneca Form Master Agreement to Streamline Research Collaborations
Nov. 28, 2006— The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today.
Sep. 21, 2006—On Saturday, Oct. 21, Vanderbilt University School of Medicine and the Melanoma Research Foundation (MRF) will host an educational symposium for melanoma patients, family and health care providers.
Sep. 14, 2006—Earlier this year, with surprisingly little media attention, we celebrated a major milestone in the fight against cancer — for the first time in record-keeping history, the number of American lives lost to cancer declined.
Aug. 24, 2006—The Vanderbilt Breast Center is offering a new class for breast cancer survivors during or after treatment, using the ancient Chinese practice of Qigong, pronounced "chee gung," to help promote renewal and restoration.
First Adult Cancer Patient in Nashville to Receive Stem Cell Transplant from Umbilical Cord Blood at Vanderbilt-Ingram Cancer Center
Jun. 8, 2006—When 24-year-old Charles Dougherty checks into Vanderbilt-Ingram Cancer Center tomorrow, he'll be preparing for a treatment that has never been performed before in an adult patient in Nashville, and will be only the second case in Tennessee history.
Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant
Apr. 17, 2006—Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.
Vanderbilt-Ingram Cancer Center Research Earns Funding from Lance Armstrong Foundation to Study Effects of Exercise on Curbing Memory Problems Associated with Chemotherapy
Mar. 20, 2006—Researchers at the Vanderbilt-Ingram Cancer Center are studying whether exercise can help curb memory and cognitive problems experienced by many cancer survivors following chemotherapy.
Mar. 15, 2006—Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. The large epidemiological study, led by Xiao-Ou Shu, M.D., Ph.D., was published online recently in the American Journal of Epidemiology.
Vanderbilt-Ingram Cancer Center Receives Funding to Identify Signals for Breast Cancer in the Blood and Women at High-Risk for the Disease
Mar. 8, 2006—A team of researchers at Vanderbilt-Ingram Cancer Center has been awarded $1.5 million from the Susan G. Komen Breast Cancer Foundation.
Vanderbilt-Ingram Cancer Center Researcher Studies Effects of Cancer Treatment among Children of Survivors
Feb. 16, 2006—Can the high doses of chemotherapy and radiation that young cancer patients receive cause inherited health problems for their children?